November 20, 2020
Pfizer Inc and its group companies filed a petition in a US court against Aurobindo Pharma Ltd and Dr. Reddy’s Laboratories alleging that the Indian drug makers were planning separately to come out with generic versions of its blockbuster multi-billion dollar drug Ibrance (Palbociclib) before the expiration of its patent. Pfizer filed the possible patent infringement case against Aurobindo Pharma in the United States District Court for the District of Delaware and Dr. Reddy’s in the New Jersey court. Palbociclib is used to treat a certain type of breast cancer and works by slowing or stopping the growth of cancer cells. Ibrance […]